Problem pulmonary pathogens: Pseudomonas aeruinosa

R Odeh1, J P Quinn

  • 1Department of Medicine, University of Illinois, Chicago 60612, USA.

Insights

Pseudomonas aeruginosa causes lethal hospital-acquired pneumonia, especially in ventilated patients. This bacterium’s virulence, biofilm formation, and antibiotic resistance mechanisms present significant treatment challenges.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a frequent cause of severe nosocomial pneumonia, particularly in mechanically ventilated patients.
  • This opportunistic pathogen is ubiquitous in the environment and possesses numerous virulence factors contributing to its pathogenicity.
  • Intrinsic antibiotic resistance, stemming from diverse mechanisms, complicates treatment strategies.

Purpose of the Study:

  • To review the virulence factors of Pseudomonas aeruginosa.
  • To discuss the mechanisms of intrinsic antibiotic resistance in P. aeruginosa.
  • To examine treatment strategies and the emergence of resistance during therapy.

Main Methods:

  • Literature review of Pseudomonas aeruginosa virulence and resistance mechanisms.
  • Analysis of treatment studies focusing on P. aeruginosa infections.
  • Examination of biofilm formation and its role in pathogenesis and resistance.

Main Results:

  • P. aeruginosa employs a wide range of virulence factors for host cell attachment, invasion, and systemic spread.
  • Biofilm formation is a key factor in P. aeruginosa pathogenesis, especially in cystic fibrosis, conferring resistance to immune clearance and antimicrobials.
  • Emergence of antibiotic resistance during therapy is a significant clinical concern, even with combination drug regimens.

Conclusions:

  • Pseudomonas aeruginosa poses a substantial threat in healthcare settings due to its virulence and resistance.
  • Understanding its molecular biology, including biofilm formation, is crucial for developing effective therapies.
  • Dual antibiotic therapy may be beneficial but does not consistently prevent the emergence of resistance.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...